Gene · 49
Papers2,647
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 2,647
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Globozoospermia-Related Gene Spata16 Is Required for Sperm Formation Revealed by CRISPR/Cas9-Mediated Mouse Models. | Int J Mol Sci | 2017 | 29065458 | PubTator, text mining | PubMed |
| Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG). | Cardiovasc Diabetol | 2017 | 29061170 | PubTator, text mining | PubMed |
| Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition: A Cross-sectional Study. | Ann Intern Med | 2017 | 29059691 | PubTator, text mining | PubMed |
| Progress and future prospect of in vitro spermatogenesis. | Oncotarget | 2017 | 29029549 | PubTator, text mining | PubMed |
| Efficacies of prevention and control measures applied during an outbreak in Southwest Madrid, Spain. | PLoS One | 2017 | 29028841 | PubTator, text mining | PubMed |
| Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay. | Clin Proteomics | 2017 | 29026368 | PubTator, text mining | PubMed |
| Clustering of chronic kidney disease and cardiovascular risk factors in South-West Nigeria. | J Nephropathol | 2017 | 28975101 | PubTator, text mining | PubMed |
| 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. | Rheumatology (Oxford) | 2017 | 28968793 | PubTator, text mining | PubMed |
| 2017 ACR/ARHP Annual Meeting Abstract Supplement. | Arthritis Rheumatol | 2017 | 28960855 | PubTator, text mining | PubMed |
| Sex-specific effects of COMT Val158Met polymorphism on corpus callosum structure: A whole-brain diffusion-weighted imaging study. | Brain Behav | 2017 | 28948081 | PubTator, text mining | PubMed |
| Prevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease. | Rheumatology (Sunnyvale) | 2017 | 28944097 | PubTator, text mining | PubMed |
| Effects of silenced PAR-2 on cell proliferation, invasion and metastasis of esophageal cancer. | Oncol Lett | 2017 | 28943918 | PubTator, text mining | PubMed |
| The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control. | Cardiovasc Diabetol | 2017 | 28915818 | PubTator, text mining | PubMed |
| Identification of Arsenic Resistance Genes from Marine Sediment Metagenome. | Indian J Microbiol | 2017 | 28904414 | PubTator, text mining | PubMed |
| Investigating simulation-based metrics for characterizing linear iterative reconstruction in digital breast tomosynthesis. | Med Phys | 2017 | 28901614 | PubTator, text mining | PubMed |
| Dose/Exposure-Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis. | CPT Pharmacometrics Syst Pharmacol | 2017 | 28891251 | PubTator, text mining | PubMed |
| Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study. | Ann Rheum Dis | 2017 | 28855173 | PubTator, text mining | PubMed |
| Risk factors for bleeding complications after nephrologist-performed native renal biopsy. | Clin Kidney J | 2017 | 28852497 | PubTator, text mining | PubMed |
| A Review of the Use of Secukinumab for Psoriatic Arthritis. | Rheumatol Ther | 2017 | 28849401 | PubTator, text mining | PubMed |
| Alternaria Toxins: Potential Virulence Factors and Genes Related to Pathogenesis. | Front Microbiol | 2017 | 28848500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/papers?page=68